Manufacturers of compounded tirzepatide and semaglutide had the ability to produce these versions while the drugs were on the FDA shortage list, and once they were removed, the FDA notified compounders that they had a transitional period to cease production
These lipotropic injections combine methionine, inositol, choline, and vitamin B12 to create a unique formula that may support metabolic functions and energy levels
Most peptide solutions should be colorless (copper peptides are an exception expect a blue-green tint)
The FDA has flagged BPC-157 because of risks like immunogenicity (it could trigger immune reactions), peptide impurities, and lack of human safety data
The primary mechanism associated with CJC-1295 appears to involve mimicking endogenous GHRH to bind GHRH receptors on somatotrophs in the anterior pituitary gland
Retrieved May 13, 2026, from: Castera MR, Borhade MB